-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UDOAH8DWYRO/JFNZ0eU1kfuZPOggKqbbzmSCHlcBSd9NhFFyAXtSIoLGbZGDilHg P6zn+dsEvctT6mgen8tK5A== 0001354457-09-000305.txt : 20091106 0001354457-09-000305.hdr.sgml : 20091106 20091106102758 ACCESSION NUMBER: 0001354457-09-000305 CONFORMED SUBMISSION TYPE: 25-NSE CONFIRMING COPY: PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20091106 DATE AS OF CHANGE: 20091106 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Hana Biosciences Inc CENTRAL INDEX KEY: 0001140028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841588441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE SEC ACT: 1934 Act SEC FILE NUMBER: 001-32626 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6505886404 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 370 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EMAIL REAL ESTATE COM INC DATE OF NAME CHANGE: 20010504 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NASDAQ Stock Market LLC CENTRAL INDEX KEY: 0001354457 IRS NUMBER: 521165937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE BUSINESS ADDRESS: STREET 1: 9600 BLACKWELL RD CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-978-4144 MAIL ADDRESS: STREET 1: 9600 BLACKWELL RD CITY: ROCKVILLE STATE: MD ZIP: 20850 25-NSE 1 primary_doc.xml X0203 0001354457 NASDAQ Stock Market LLC 0001140028 Hana Biosciences Inc 001-32626
7000 Shoreline Court, Suite 370 San Francisco CA CALIFORNIA 94080
650-588-6404 Common Stock 17 CFR 240.12d2-2(b) Amy Horton Associate General Counsel 2009-11-06 EX-99.25 2 hnabdelistreason.txt Delisting Determination,The Nasdaq Stock Market, LLC, November 6, 2009, Hana Biosciences, Inc. The Nasdaq Stock Market, Inc. (the Exchange) has determined to remove from listing the common stock of Hana Biosciences, Inc. (the Company), effective at the opening of the trading session on November 16, 2009. Based on review of information provided by the Company, Nasdaq Staff determined that the Company no longer qualified for listing on the Exchange pursuant to Listing Rule 5550(b)(1). The Company was notified of the Staffs determination on March 5, 2009. The Company requested a review of the Staffs determination before the Listing Qualifications Hearings Panel. Upon review of the information provided by the Company, the Panel issed a decision dated June 8, 2009, granting the COmpany an exception until September 1, 2009, conditioned upon the Company's regaining compliance by that date. On September 8, 2009, the Panel issued a decision notifying the Company that because it had not regained compliance with Rule 5550(b)(1),it did not qualify for inclusion on the Exchange. Trading in the Companys securities was suspended on September 10, 2009. The Company did not request a review of the Panels decision by the Nasdaq Listing and Hearing Review Council. The Listing Council did not call the matter for review. The Panels Determination to delist the Company became final on October 23, 2009. -----END PRIVACY-ENHANCED MESSAGE-----